Skip to content

Effectiveness of near-infrared spectroscopy neurofeedback for psychiatric disorders

Effectiveness of near-infrared spectroscopy neurofeedback for psychiatric disorders - Effectiveness of NIRS-based neurofeedback

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035489
Enrollment
300
Registered
2019-01-10
Start date
2019-01-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depression, Bipolar disorder, Anxiety disorder, Autism spectrum disorder, Attention-deficit/hyperactivity disorder, and Healthy control

Interventions

We conduct a maximum of 20 NFB at a pace of 2-5 days per week.

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Patient group People who were diagnosed with major depression, bipolar disorder, anxiety disorder, ASD, ADHD in DSM-5 2 Healthy control group A healthy person without a history of mental illness

Exclusion criteria

Exclusion criteria: People who satisfies one of the following 1 Combined circulatory organ, liver, kidney, respiratory organs, blood, endocrine, central nervous system diseases, and person who was judged to be extremely unstable 2 Person who has history of head trauma or substance dependence 3 People with a history of epilepsy or generalized convulsions 4 For healthy control subjects, those who are diagnosed with developmental disorder

Design outcomes

Primary

MeasureTime frame
1 Clinical evaluation scale HAM-D, HAM-A, MADRAS, etc. 2 Neuropsychological examination TMT, BADS, CAT, CANTAB, etc.

Countries

Japan

Contacts

Public ContactBun Yamagata

Keio University School of Medicine Department of Neuropsychiatry

yamagata@a6.keio.jp03-5363-3971

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026